Efficacy of a spot-on formulation containing 280 mg/ml fluralaner and 14 mg/ml moxidectin (Bravecto® Plus) in the prevention of cat aelurostrongylosis under field conditions.

MLA

Di Cesare, Angela, et al. “Efficacy of a Spot-on Formulation Containing 280 Mg/Ml Fluralaner and 14 Mg/Ml Moxidectin (Bravecto® Plus) in the Prevention of Cat Aelurostrongylosis under Field Conditions.” Veterinary Parasitology, vol. 327, Apr. 2024, p. 110114. EBSCOhost, https://doi.org/10.1016/j.vetpar.2024.110114.

APA

Di Cesare, A., Morelli, S., Rohdich, N., Kirkova, Z., Capári, B., Loehlein, W., Wolf, O., Zschiesche, E., Colombo, M., Astuti, C., & Traversa, D. (2024). Efficacy of a spot-on formulation containing 280 mg/ml fluralaner and 14 mg/ml moxidectin (Bravecto® Plus) in the prevention of cat aelurostrongylosis under field conditions. Veterinary Parasitology, 327, 110114. https://doi.org/10.1016/j.vetpar.2024.110114

Chicago

Di Cesare, Angela, Simone Morelli, Nadja Rohdich, Zvezdelina Kirkova, Balázs Capári, Wolfgang Loehlein, Oliver Wolf, et al. 2024. “Efficacy of a Spot-on Formulation Containing 280 Mg/Ml Fluralaner and 14 Mg/Ml Moxidectin (Bravecto® Plus) in the Prevention of Cat Aelurostrongylosis under Field Conditions.” Veterinary Parasitology 327 (April): 110114. doi:10.1016/j.vetpar.2024.110114.